Nick Vitanza: It’s been a dream to bring better treatments to kids with DIPG and CNS tumors

Nick Vitanza, the Director of the Vitanza Lab at the Ben Towne Center for Childhood Cancer Research, posted on X/Twitter:

“It’s been a dream to bring better treatments to kids with DIPG and CNS tumors. It’s thrilling to announce BrainChild Bio a kids first biotech advancing CAR-T cells for CNS tumors (CEO Steve Brugger; CSO Mike Jensen, MD) in partnership with Seattle Children’s Hospital.”

Read more here.
Source: Nick Vitanza/X